Research Horizons

Search

CRISPR-Edited Mice Help Reveal Potential Nanoparticle Treatment for ACDMPV

This confocal microscopic image shows FOXF1 deficient fetal lung cells from mice. FOXF1 deficiency inhibits the normal development and proliferation of lung cells and helps cause a fatal disease in infants called Alveolar Capillary Dysplasia with Misalignment of Pulmonary Veins.

Alveolar Capillary Dysplasia with Misalignment of Pulmonary Veins (ACDMPV) is a very rare congenital respiratory disorder that usually proves fatal to infants within a month of birth.

But new findings from researchers at Cincinnati Children’s suggest a potential step forward toward longer survival.

Scientists here used CRISPR/Cas9 to generate mice that faithfully mimic the disorder. The new mouse model allowed researchers to pinpoint the disorder’s cause and identify a potential nanoparticle-based treatment.

Findings appear in the  American Journal of Respiratory and Critical Care Medicine.

Read more

Publication Information
Original title: The S52F FOXF1 Mutation Inhibits STAT3 Signaling and Causes Alveolar Capillary Dysplasia
Published in: American Journal of Respiratory and Critical Care Medicine
Publish date: June 14, 2019
Read the study

Research By

kalinichenko-4x3-1024x768-e1623428524850.jpg
Vladimir Kalinichenko, MD, PhD
Division of Pulmonary Biology
The Kalinichenko lab investigates novel transcriptional mechanisms critical for embryonic lung development, lung injury/repair and lung carcinogenesis.